DOXIL - Resource Library

DOXIL—Resource Library

The following resources are provided to our Web site visitors to assist you, working with your healthcare professional, in making the most appropriate decision about your treatment options and specifically, DOXIL therapy.

Cancer and Intimacy
A presentation by Jeanne Carter, PhD from the Department of Psychiatry/Gynecology Service at the Memorial Sloan-Kettering Cancer Center, at Gilda’s Club in New York City. (160KB, PDF)

Meet the Challenge: What to Expect from DOXIL
This informative video features information on DOXIL, tips to help you manage any side effects you may be experiencing and informative narration from key opinion leaders in the oncology field. (Online Video)

Nutrition Knowledge is Power
A presentation by Patricia Slinger, Registered Dietician and Director of Nutrition Services for God’s Love We Deliver, at the Celebrating Survivors launch event at Gilda’s Club in New York City. (143KB, PDF)

Questions or Topics to Discuss with Your Doctor
This document features a list of suggested questions for you and your doctor to consider while determining your treatment options. (92KB, PDF)

Questions and Answers About DOXIL
This document offers basic information about DOXIL and what to expect with DOXIL therapy in a simple, question and answer format. It also includes a glossary and questions to ask your healthcare professional about DOXIL. (399KB, PDF)

Tips and Suggestions for Patients Receiving Treatment
Actively manage your side effects with the helpful tips and suggestions contained in this document. It also includes a page to log your personal treatment schedule. (202KB, PDF)

RELATED RESOURCES

FREQUENTLY ASKED QUESTIONS

GLOSSARY

Doxil (doxorubicin HCl), is a prescription medicine that is administered intravenously by your healthcare professional. DOXIL is used to treat patients with ovarian cancer that has progressed or recurred after platinum-based chemotherapy.

Please read Important Safety Information below, and talk to your healthcare professional to learn more about DOXIL.

Important Safety Information

Serious and possibly permanent heart-related side effects that may lead to congestive heart failure can occur in patients treated with DOXIL. Inform your doctor of any history of heart disease, radiation to your chest, or prior chemotherapy. Your doctor may monitor your heart function.
Infusion reactions may occur during administration. Be sure to tell your doctor if you have any symptoms during infusion, including: flushing, shortness of breath, facial swelling, headaches, chills, back pain, tightness in your chest or throat, dizziness, or lightheadedness. For most patients, these reactions have resolved within several hours to a day once the infusion is stopped, or for some patients with slowing of the infusion rate. However, in some cases, these reactions may be serious and sometimes life threatening, though they are rarely fatal.

DOXIL may severely reduce the number of blood cells (red blood cells, white blood cells, and platelets) in your body. Your doctor may adjust or delay your dose of DOXIL if this occurs.

Your doctor may adjust your dose of DOXIL if you have liver problems.

You should not take DOXIL if you are nursing. If you are pregnant or are planning to become pregnant, inform your doctor.

You should not take DOXIL if you are allergic to doxorubicin HCI or the components of DOXIL.

The most common side effects of DOXIL are:

Hand-Foot Syndome (HFS): Tingling or burning, redness, flaking, bothersome swelling, small blisters, or small sores on palms of hands or soles of feet
Stomatitis: Painful redness, swelling, or sores in the mouth
Fever: A fever of 100.5^oF or higher
Neutropenia: Low white blood cell count
Nausea, vomiting, tiredness, weakness, rash, shortness of breath, or mild hair loss
Loss of appetite
Diarrhea

Be sure to tell your doctor immediately if you experience any of these or other symptoms.

DOXIL may make the side effects of other anticancer therapies worse when used in combination.

Following administration, DOXIL may turn urine and other bodily fluids a reddish-orange color. This is due to the color of DOXIL and will go away as the drug leaves the body.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088 (1-800-332-1088).

Please click here for full Product Information in PDF format,for more details.